SCHEMBL23813720

SCHEMBL23813720

CC(=O)CCOCCOCCOCCOCCOCCC(=O)ON1C(=O)CC(S(=O)(=O)O)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22038805 0.94 — —
SCHEMBL22549366 0.94 — —
SCHEMBL22057295 0.86 — —
SCHEMBL15281651 0.85 PRKCA (0.32) —
SCHEMBL28455474 0.84 — —
SCHEMBL22057294 0.84 — —
SCHEMBL20801353 0.83 — —
SCHEMBL20801357 0.83 — —
SCHEMBL22180988 0.83 — —
SCHEMBL20801483 0.82 NAAA (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284750-A1 Immunoconjugate Synthesis Method BOLT BIOTHERAPEUTICS, INC. (US) 2021-09-16 — — US disclosed
Send feedback